Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid Tumors

Conditions:   Solid Tumor;   Hepatocellular Carcinoma;   Gastric Cancer;   Gastroesophageal Junction Adenocarcinoma
Interventions:   Drug: Vorolanib;   Drug: Nivolumab;   Drug: Pembrolizumab;   Procedure: Peripheral blood draw
Sponsors:   Washington University School of Medicine;   Xcovery Holding Company, LLC
Not yet recruiting

https://ift.tt/2HvlYcQ